Certified by Founder Lodge
nVentures
Singapore - ND
INVESTOR
1 Disclosed Funding Rounds $26,200,000
40 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Building a startup is hard. We know because we did it. Not once, multiple times! Scaling and successfully exiting is a lot harder. We know because we did that too!! We understand the struggle
| Company | Date | Round | Raised |
|---|---|---|---|
 Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
 Neocis |
January, 15 ,2024 | Unknown | $20,000,000 |
 Arsenal Biosciences, Inc. |
September, 04 ,2024 | Series C | $325,000,000 |
| Neocis |
January, 15 ,2024 | Unknown | $20,000,000 |
 Exa |
July, 17 ,2024 | Series A | $22,000,000 |
 Relation |
March, 15 ,2024 | Seed | $35,000,000 |
 Outrider |
October, 25 ,2024 | Series D | $62,000,000 |
 Ubie |
August, 22 ,2022 | Series C | $26,200,000 |
| Relation |
March, 15 ,2024 | Seed | $35,000,000 |
 Seurat Technologies |
October, 31 ,2023 | Series C | $99,000,000 |
| Exa |
July, 17 ,2024 | Series A | $22,000,000 |
 Profound |
June, 24 ,2025 | Series A | $20,000,000 |
| Generate:Biomedicines |
September, 18 ,2023 | Series C | $273,000,000 |
| Arsenal Biosciences, Inc. |
September, 04 ,2024 | Series C | $325,000,000 |
| Arsenal Biosciences, Inc. |
September, 04 ,2024 | Series C | $325,000,000 |
 Terray Therapeutics |
November, 10 ,2023 | Unknown | |
| Exa |
July, 17 ,2024 | Series A | $22,000,000 |
| Outrider |
October, 25 ,2024 | Series D | $62,000,000 |
| Outrider |
October, 25 ,2024 | Series D | $62,000,000 |
 Replicate |
December, 07 ,2023 | Series B | $40,000,000 |
| Seurat Technologies |
October, 31 ,2023 | Series C | $99,000,000 |
| Neocis |
January, 15 ,2024 | Unknown | $20,000,000 |
| Profound |
June, 24 ,2025 | Series A | $20,000,000 |
| Relation |
March, 15 ,2024 | Seed | $35,000,000 |
| Arsenal Biosciences, Inc. |
September, 04 ,2024 | Series C | $325,000,000 |
| Exa |
July, 17 ,2024 | Series A | $22,000,000 |
| Terray Therapeutics |
November, 10 ,2023 | Unknown | |
| Arsenal Biosciences, Inc. |
September, 04 ,2024 | Series C | $325,000,000 |
| Outrider |
October, 25 ,2024 | Series D | $62,000,000 |
| Outrider |
October, 25 ,2024 | Series D | $62,000,000 |
| Replicate |
December, 07 ,2023 | Series B | $40,000,000 |
| Profound |
June, 24 ,2025 | Series A | $20,000,000 |
| Neocis |
January, 15 ,2024 | Unknown | $20,000,000 |
 Emerald AI |
July, 02 ,2025 | Seed | $24,500,000 |
| Relation |
March, 15 ,2024 | Seed | $35,000,000 |
| Exa |
July, 17 ,2024 | Series A | $22,000,000 |
| Arsenal Biosciences, Inc. |
September, 04 ,2024 | Series C | $325,000,000 |
| Outrider |
October, 25 ,2024 | Series D | $62,000,000 |
| Profound |
June, 24 ,2025 | Series A | $20,000,000 |
| Emerald AI |
July, 02 ,2025 | Seed | $24,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
